Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
6.20
+0.11 (1.81%)
May 9, 2025, 4:00 PM - Market closed
Pulmatrix Employees
Pulmatrix had 2 employees as of December 31, 2024. The number of employees decreased by 20 or -90.91% compared to the previous year.
Employees
2
Change (1Y)
-20
Growth (1Y)
-90.91%
Revenue / Employee
$3,903,000
Profits / Employee
-$4,779,500
Market Cap
22.64M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
PULM News
- 7 weeks ago - Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets - PRNewsWire
- 6 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders - Accesswire
- 6 months ago - PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc. - PULM - Business Wire
- 6 months ago - Pulmatrix and Cullgen Announce Proposed Merger - PRNewsWire
- 6 months ago - Pulmatrix Announces Third Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 9 months ago - Pulmatrix Announces Second Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 1 year ago - Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation - PRNewsWire
- 1 year ago - Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100) - PRNewsWire